ABcann Medicinals has received its full facility approval from Health Canada. ABcann can now “flip” their plants they currently have growing. This will allow the plants to flower, putting ABcann one step closer to selling their product.
Health Canada Gives LP the OK to Flip Rooms
“Full room approval has been provided and dictates that all bloom rooms, growth chambers, vegetation room, clean/general horticulture rooms, processing and drying areas, as well as ABcann’s in house laboratory, have been given Health Canada’s blessing to commence full production activities,” says Tim Humberstone of ABcann.
This room approval came in the midst of the fallout from the R. v. Smith decision and Health Canada‘s response. On July 8th, 2015 Health Canada issued a statement that issued a Section 56 exemption under the Controlled Drugs and Substances Act (CDSA) allowing licensed producers to produce and sell cannabis oil and fresh cannabis. ABcann is in the process of applying to develop cannabis oil which will undergo the same testing procedures as dried cannabis and will carry the same rules and requirements before it can be sold.